ProCE Banner Activity

CD38-Targeted Antibodies in Transplant-Eligible and Transplant-Ineligible Patients With Myeloma

Slideset

Downloadable slideset from a live webinar covering the use of CD38-targeted antibodies in the management of newly diagnosed multiple myeloma.

Released: July 24, 2024

Expiration: July 23, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi